PDA Workshop: Artificial Intelligence, a Revolution in Pharma Manufacturing

The Parenteral Drug Association's two-day Berlin workshop focuses on putting artificial intelligence into pharmaceutical manufacturing within demanding quality and regulatory settings. Sessions bring together industry, regulators, standards bodies and AI practitioners to develop practical approaches to reliable adoption.

Topics include the full AI lifecycle in GxP environments, evolving frameworks such as Annex 22 and FDA AI/ML initiatives, and real-world governance, quality and patient-safety considerations. The first day's agenda begins at 09:00 CET, with an interactive panel on global AI good practices among the listed sessions. Individual and group registration are open through PDA.